Eli Lilly’s Zepbound is still viewed as the leading weight-loss shot, according to a market analyst who compared the drug to a rival injection from Pfizer. The comment comes as drugmakers race to meet ... Eli Lilly said its closely watched obesity pill helped patients maintain the majority of their weight loss after they switched directly from taking Wegovy and Zepbound injections in a late-stage trial ...

Understanding the Context

NBC 10 Philadelphia: Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says A previous update said some doses of the treatments were still in short supply. Some doses of Mounjaro have been in shortage since as early as 2022, while doses of Zepbound joined the FDA's shortage ... Eli Lilly's Zepbound and Mounjaro now available in U.S.

Key Insights

after shortages, FDA says AOL: Everything You Need To Know About Zepbound for Weight Loss, Including Costs Everything You Need To Know About Zepbound for Weight Loss, Including Costs Seeking Alpha: Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen